期刊文献+

肺血栓栓塞后组织型纤溶酶原激活物及其抑制物-1在肺动脉中的表达 被引量:4

Expression of tissue plasminogen activator and inhibitor-1 after acute pulmonary thromboembolism in rabbit
下载PDF
导出
摘要 目的通过研究兔实验性肺血栓栓塞(PTE)后组织型纤溶酶原激活物(t-PA)及其抑制物-1(PAI-1)在肺动脉中表达的动态变化,了解急性肺栓塞后机体纤溶能力的变化。方法将48只日本健康大耳白兔,随机分为栓塞组和对照组。栓塞组利用自体血栓经股静脉输入建立PTE模型,对照组输入生理盐水。用免疫组织化学及Westernblot方法检测对照组及栓塞后即刻、4、8、24h栓塞部位肺动脉组织中t-PA及PAI-1蛋白表达水平。结果t-PA在栓塞后即刻和4h未见明显表达,8h和24h表达明显增强;半定量蛋白结果显示t-PA在栓塞后4h表达开始增高,8h进一步增强,24h达高峰。与各对照组比较,有显著性差异(P<0·05)。PAI-1在栓塞后即刻及24h均见明显表达,而在栓塞后4h和8h表达明显减少;半定量蛋白结果显示PAI-1在栓塞后4h开始降低,8h降至低峰,与各对照组比较,有显著性差异(P<0·05)。PAI-1在栓塞后24h表达有所恢复。结论兔急性肺栓塞后,t-PA表达水平随时间而逐渐增高,PAI-1表达呈现一过性降低,表明了在肺动脉栓塞早期,机体的纤溶功能明显增强,这与肺血管的t-PA和PAI-1表达平衡变化有关。 Objective To study the changes in tissue plasminogen activator(t PA) and inhibitor-1(PAI-1) expression in pulmonary artery after acute pulmonary thromboembolism(PTE). Methods Rabbit acute pulmonary thromboembolism model was established by injection of auto-blood clots into femoral vein. Control group received injection of the same volume normal saline. The expression of t PA and PAI-1 was measured by immunohistochemical and Western blot at 0, 4,8 and 24 h after PTE. Results t-PA stainig was shown in the endothelial cells of the morbid pulmonary artery at 8 h after PTE but not in normal or morbid pulmonary artery at 4 h after PTE, which was supported by Western blot data. So did the results of PAI-1 staining. Conclusion The results indicate that the fibrinolysis activity is enhanced greatly after the early state of PTE in rabbit,and the balance between t-PA and PAI-1 is shifed, which might be helpful for lysis of the embolus.
出处 《江苏医药》 CAS CSCD 北大核心 2006年第9期838-840,F0002,共4页 Jiangsu Medical Journal
关键词 组织型纤溶酶原激活剂 组织型纤溶酶原激活剂抑制物-1 肺栓塞 Tissue plasminogen activator a Plasminogen activator inhibitor-1 Pulmonary thromboembolism
  • 相关文献

参考文献7

  • 1倪松石,贲素琴,施裕新,黄石兵,黄剑飞.实验性肺血栓栓塞症血浆D-二聚体的动态研究[J].中华结核和呼吸杂志,2003,26(12):803-804. 被引量:4
  • 2Levin EG,Banka CL,Parry GC.Progressive and transient expression of tissue plasminogen activator during fetal development.Arteriosclerosis,Thrombosis and Vascular Biology,2000,20:1668-1674.
  • 3Lang IM,Moser KM,Schleef RR.Elevated expression of ruokinase-like plasminogen activator and plasminogen activator inhibitor type-1 during the vascular remodeling associated with pulmonary thromboembolism.Arteriosclerosis,Thrombosis and Vascular Biology,1998,18:808-815.
  • 4Siren VA,Kauhanen PB,Carpen OD,et al.Urokinase,tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis.Blood Coagulation and Fibrinolysis,2003,14:369-377.
  • 5Rosenhek R,Korschineck I,Gharehbaghi-Schnell E,et al.Fibrinolytic balance of the arterial wall:pulmonary artery displays increased fibrinolytic potential compared with aorta.Laboratory Investigation,2003,83:871-876.
  • 6Nicholls SC,Hoffer EK,Chandler WL.Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type-1.Blood Coagulation and Fibrinolysis,2003,14:729-773.
  • 7倪松石,贲素琴,施裕新,徐建辉.犬实验性肺血栓栓塞症后血乳酸脱氢酶及其同功酶的动态研究[J].江苏医药,2004,30(3):180-181. 被引量:2

二级参考文献1

共引文献4

同被引文献45

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部